ApoGlyx
A virtual biotech company focused on developing oral therapy for type 2 diabetes patients in the pre-clinical stage.
1
Funding Rounds
$700.0k
Money raised
Overview
A virtual biotech company focused on developing oral therapy for type 2 diabetes patients in the pre-clinical stage.
- Website:
- Business model: B2B
- Headquarters: Lund
- Social accounts: linkedin
Funding series
Funding Series Analysis
The company ApoGlyx has raised a total of $700k in funding over 1 rounds.
Key Insights:
- ApoGlyx October 2021 Funding Round: $700k
ApoGlyx October 2021 Funding Round
$700k